- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00944242
Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting Conditions
July 22, 2009 updated by: Torrent Pharmaceuticals Limited
Objective:
- To compare the rate and extent of absorption of Torrent Pharmaceuticals Limited, India, sertraline and Pfizer, Inc., USA (Zoloft) sertraline, administered as a 1X100 mg tablet, under fasted conditions.
Study Design:
- Single-dose, open-label, randomized two-way crossover.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada
- Anapharm Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female, smoker or non smoker, 18 years of age and older.
- Capable of consent.
- BMI>= 19.0 and <30.0 kg/m2
- Exclusion Criteria:
Subjects to whom any of the following applies will be excluded from the study:
- Clinically significant illness or surgery within 4 weeks prior to the administration of the study medication.
- Positive testing for hepatitis B, hepatitis C, or HIV at screening.
- ECG abnormalities or vital sign abnormalities(blood pressure).
- History of significant alcohol or drug abuse within one year prior to the screening visit.
- History or allergic reactions to heparin, sertraline or other related drugs.
- Use of an investigational drug or participation in an investigational study with in 30 days prior to administration of the study medication.
- Clinically significant history of gastrointestinal pathology, liver or kidney disease, neurological, cardiovascular, pulmonary, hematologic, immunologic, psychiatric or metabolic disease.
- History of seizures, suicide attempt, bipolar disorder or manic episodes.
- Depot injection or an implant of any drugs with in 6 months prior to administration of study medication.
- Breastfeeding subject.
- Positive urine pregnancy test at screening.
- female subject of child bearing potential having unprotected sexual intercourse with any non-sterile mail partner within 14 days prior to study drug administration.
Acceptable methods of contraception:
- Intra-uterine contraceptive device(placed at least 4 weeks prior to study drug administration)
- Condom or diaphragm + spermicide.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
July 21, 2009
First Submitted That Met QC Criteria
July 22, 2009
First Posted (Estimate)
July 23, 2009
Study Record Updates
Last Update Posted (Estimate)
July 23, 2009
Last Update Submitted That Met QC Criteria
July 22, 2009
Last Verified
July 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 40485
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Sertraline
-
Beijing HuiLongGuan HospitalCompleted
-
Maastricht University Medical CenterPfizerCompletedDepression | Chest Pain | Panic AttacksNetherlands
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
University of Sao PauloCompletedObsessive-Compulsive DisorderBrazil
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedDepression | Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Angina, UnstableUnited States
-
TakedaCompletedCrohn's Disease | Ulcerative ColitisBelgium, United States, Korea, Republic of, Malaysia, Canada, Israel, Australia, Hungary, Czechia, Germany
-
University of PittsburghCompleted
-
Su RuiUnknown
-
Rhode Island HospitalStanford University; University of Cincinnati; American Epilepsy Society; Epilepsy...CompletedDepression | Stress Disorders, Post-Traumatic | Dissociative Disorders | Conversion Disorder | Convulsion, Non-EpilepticUnited States
-
TakedaCompleted